Market Research

Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Type (Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests), By Application (Infectious D

Best Price Guarantee Publisher Published Date SKU
from $3,500 Straits Research November, 2024 STRA19656067
Best Price Guarantee
Price from $3,500
Publisher Straits Research
Published Date November, 2024
SKU STRA19656067

Nucleic Acid Amplification Testing Market Analysis and Insights

The Nucleic Acid Amplification Testing Market size is anticipated to reach USD 10.11 billion in 2024 and it is projected to reach USD 23.74 billion by 2033, growing at a CAGR of 12.2% during the forecast period.

The Global Nucleic Acid Amplification Testing Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis.

The Global Nucleic Acid Amplification Testing Market growth, Size report provides a comprehensive analysis of the Healthcare IT industry, analyzes and identifies changes in market conditions set to impact future business decisions by analyzing.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Nucleic Acid Amplification Testing Market includes major supplies & Independent Consultants among others.

Global Market Scope and Nucleic Acid Amplification Testing Market

The scope of the report is to provide a 360-degree view of the market outlook by assessing the entire value chain and analyzing the key Nucleic Acid Amplification Testing Market trends from 2024 to 2032 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Nucleic Acid Amplification Testing Market Country Level Analysis

The Global Nucleic Acid Amplification Testing Market Industry Analysis Research Report provides a basic overview of industry dominating market share expected 2024 to 2032. A detailed section on Nucleic Acid Amplification Testing Market share and status of critical industries is included in the report, covering. Market Segment by Regions (North America, Europe, Asia Pacific, South America and The Middle East and Africa), coverage with region wise data from 2024 to 2032.

Top Players in Nucleic Acid Amplification Testing Market

Some of the other major highlights of the demand for Nucleic Acid Amplification Testing Market include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Nucleic Acid Amplification Testing Market during the forecast period.

  • Becton, Dickinson, and Company
  • Danaher Corporation
  • Illumina, Inc.
  • Siemens Healthineers
  • bioMérieux SA
  • Novartis AG
  • Bio-Rad Laboratories, Inc.
  • Seegene Inc.
  • Agilent Technologies
  • Siemens Healthineers
  • BioMérieux
  • GenMark Diagnostics
  • Visby Medical

Market Segmentation

The Global Nucleic Acid Amplification Testing Market Share, Demand provides the most up-to-date Healthcare IT industry data on the actual market situation, size, trends and future outlook. The research includes historic data from 2021 to 2023 and forecasts until 2032.
  • By Type
    • Polymerase Chain Reaction (PCR) Tests
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • Ligase Chain Reaction (LCR) Tests
  • By Application
    • Infectious Disease Testing
      • COVID-19 Testing
      • Mosquito-Borne Disease Testing
      • Influenza Testing
      • Sexually Transmitted Infections Testing
      • Hepatitis Testing
      • Tuberculosis Testing
      • Others
    • Oncology Testing
    • Genetic Testing
    • Others
  • By End-User
    • Hospitals
    • Diagnostic laboratories
    • Others

Regions Coverd
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Nordic
    • Benelux
    • Rest of Europe
  • APAC
    • China
    • Korea
    • Japan
    • India
    • Australia
    • Singapore
    • Taiwan
    • South East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • UAE
    • Turkey
    • Saudi Arabia
    • South Africa
    • Egypt
    • Nigeria
    • Rest of MEA
  • LATAM
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Rest of LATAM

Reasons for Doing the Study:

This report is an update of an earlier (2023) Research study. Since the previous edition of this report was published, the Public Safety and Security market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.


1 Executive Summary
2 Research Scope & Segmentation
2.1 Research Objectives
2.2 Limitations & Assumptions
2.3 Market Scope & Segmentation
2.4 Currency & Pricing Considered
3 Market Opportunity Assessment
3.1 Emerging Regions / Countries
3.2 Emerging Companies
3.3 Emerging Applications / End Use
4 Market Trends
4.1 Drivers
4.2 Market Warning Factors
4.3 Latest Macro Economic Indicators
4.4 Geopolitical Impact
4.5 Technology Factors
5 Market Assessment
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
6 Global Nucleic Acid Amplification Testing Market Size Analysis
6.1 By Type
6.1.1 Polymerase Chain Reaction (PCR) Tests
6.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
6.1.3 Ligase Chain Reaction (LCR) Tests
6.2 By Application
6.2.1 Infectious Disease Testing
6.2.1.1 COVID-19 Testing
6.2.1.2 Mosquito-Borne Disease Testing
6.2.1.3 Influenza Testing
6.2.1.4 Sexually Transmitted Infections Testing
6.2.1.5 Hepatitis Testing
6.2.1.6 Tuberculosis Testing
6.2.1.7 Others
6.2.2 Oncology Testing
6.2.3 Genetic Testing
6.2.4 Others
6.3 By End-User
6.3.1 Hospitals
6.3.2 Diagnostic laboratories
6.3.3 Others
7 North America Market Analysis
7.1 By Type
7.1.1 Polymerase Chain Reaction (PCR) Tests
7.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
7.1.3 Ligase Chain Reaction (LCR) Tests
7.2 By Application
7.2.1 Infectious Disease Testing
7.2.1.1 COVID-19 Testing
7.2.1.2 Mosquito-Borne Disease Testing
7.2.1.3 Influenza Testing
7.2.1.4 Sexually Transmitted Infections Testing
7.2.1.5 Hepatitis Testing
7.2.1.6 Tuberculosis Testing
7.2.1.7 Others
7.2.2 Oncology Testing
7.2.3 Genetic Testing
7.2.4 Others
7.3 By End-User
7.3.1 Hospitals
7.3.2 Diagnostic laboratories
7.3.3 Others
7.3 U.S.
7.4 Canada
8 Europe Market Analysis
8.1 By Type
8.1.1 Polymerase Chain Reaction (PCR) Tests
8.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
8.1.3 Ligase Chain Reaction (LCR) Tests
8.2 By Application
8.2.1 Infectious Disease Testing
8.2.1.1 COVID-19 Testing
8.2.1.2 Mosquito-Borne Disease Testing
8.2.1.3 Influenza Testing
8.2.1.4 Sexually Transmitted Infections Testing
8.2.1.5 Hepatitis Testing
8.2.1.6 Tuberculosis Testing
8.2.1.7 Others
8.2.2 Oncology Testing
8.2.3 Genetic Testing
8.2.4 Others
8.3 By End-User
8.3.1 Hospitals
8.3.2 Diagnostic laboratories
8.3.3 Others
8.3 U.K.
8.4 Germany
8.5 France
8.6 Spain
8.7 Italy
8.8 Russia
8.9 Nordic
8.10 Benelux
8.11 Rest of Europe
9 APAC Market Analysis
9.1 By Type
9.1.1 Polymerase Chain Reaction (PCR) Tests
9.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
9.1.3 Ligase Chain Reaction (LCR) Tests
9.2 By Application
9.2.1 Infectious Disease Testing
9.2.1.1 COVID-19 Testing
9.2.1.2 Mosquito-Borne Disease Testing
9.2.1.3 Influenza Testing
9.2.1.4 Sexually Transmitted Infections Testing
9.2.1.5 Hepatitis Testing
9.2.1.6 Tuberculosis Testing
9.2.1.7 Others
9.2.2 Oncology Testing
9.2.3 Genetic Testing
9.2.4 Others
9.3 By End-User
9.3.1 Hospitals
9.3.2 Diagnostic laboratories
9.3.3 Others
9.3 China
9.4 Korea
9.5 Japan
9.6 India
9.7 Australia
9.8 Taiwan
9.9 South East Asia
9.10 Rest of Asia-Pacific
10 Middle East and Africa Market Analysis
10.1 By Type
10.1.1 Polymerase Chain Reaction (PCR) Tests
10.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
10.1.3 Ligase Chain Reaction (LCR) Tests
10.2 By Application
10.2.1 Infectious Disease Testing
10.2.1.1 COVID-19 Testing
10.2.1.2 Mosquito-Borne Disease Testing
10.2.1.3 Influenza Testing
10.2.1.4 Sexually Transmitted Infections Testing
10.2.1.5 Hepatitis Testing
10.2.1.6 Tuberculosis Testing
10.2.1.7 Others
10.2.2 Oncology Testing
10.2.3 Genetic Testing
10.2.4 Others
10.3 By End-User
10.3.1 Hospitals
10.3.2 Diagnostic laboratories
10.3.3 Others
10.3 UAE
10.4 Turkey
10.5 Saudi Arabia
10.6 South Africa
10.7 Egypt
10.8 Nigeria
10.9 Rest of MEA
11 LATAM Market Analysis
11.1 By Type
11.1.1 Polymerase Chain Reaction (PCR) Tests
11.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
11.1.3 Ligase Chain Reaction (LCR) Tests
11.2 By Application
11.2.1 Infectious Disease Testing
11.2.1.1 COVID-19 Testing
11.2.1.2 Mosquito-Borne Disease Testing
11.2.1.3 Influenza Testing
11.2.1.4 Sexually Transmitted Infections Testing
11.2.1.5 Hepatitis Testing
11.2.1.6 Tuberculosis Testing
11.2.1.7 Others
11.2.2 Oncology Testing
11.2.3 Genetic Testing
11.2.4 Others
11.3 By End-User
11.3.1 Hospitals
11.3.2 Diagnostic laboratories
11.3.3 Others
11.3 Brazil
11.4 Mexico
11.5 Argentina
11.6 Chile
11.7 Colombia
11.8 Rest of LATAM
12 Competitive Landscape
12.1 Global Nucleic Acid Amplification Testing Market Share By Players
12.2 M & A Agreements & Collaboration Analysis
13 Market Players Assessment
13.2 Becton, Dickinson, and Company
13.3 Danaher Corporation
13.4 Illumina, Inc.
13.5 Siemens Healthineers
13.6 bioMérieux SA
13.7 Novartis AG
13.8 Bio-Rad Laboratories, Inc.
13.9 Seegene Inc.
13.10 Agilent Technologies
13.11 BioMérieux
13.12 GenMark Diagnostics
13.13 Visby Medical
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Major secondary sources
14.1.1.2 Key data from secondary sources
14.1.2 Primary Data
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primaries
14.1.3 Secondary And Primary Research
14.1.3.1 Key industry insights
14.2 Market Size Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach
14.2.3 Market Projection
14.3 Research Assumptions
14.3.1 Assumptions
14.4 Limitations
14.5 Risk Assessment
15 Appendix
15.1 Discussion Guide
15.2 Customization Options
15.3 Related Reports
16 Disclaimer

$3,500
$4,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings